Oncolytics Biotech Q3 Results Scheduled for October 30
The company is expected to report Q3'26 results on October 30. Revenue is estimated at 0 USD and EPS at (0.05) USD; the release time is not specified.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.